- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Close Asset Management Ltd Reduces Holdings in Johnson & Johnson $JNJ
The fund sold 27,299 shares of the healthcare company in the third quarter.
Feb. 27, 2026 at 9:33am
Got story updates? Submit your updates here. ›
Close Asset Management Ltd reduced its stake in Johnson & Johnson (NYSE:JNJ) by 30.0% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 63,819 shares of the company's stock after selling 27,299 shares during the quarter. Close Asset Management Ltd's holdings in Johnson & Johnson were worth $11,832,000 as of its most recent SEC filing.
Why it matters
This filing provides insight into the investment strategy and portfolio adjustments of Close Asset Management Ltd, a major institutional investor. Changes in holdings of large investors can influence the stock price and trading volume of the affected companies.
The details
Close Asset Management Ltd reduced its position in Johnson & Johnson by selling 27,299 shares in the third quarter. The fund now owns 63,819 shares of the healthcare company's stock, valued at $11,832,000 as of the latest SEC filing. This represents a 30.0% decrease in the fund's holdings of Johnson & Johnson.
- Close Asset Management Ltd filed the 13F report for the third quarter of 2026.
The players
Close Asset Management Ltd
A major institutional investor that manages a portfolio of investments, including shares of Johnson & Johnson.
Johnson & Johnson
A multinational healthcare company that develops, manufactures, and markets a broad range of products across pharmaceuticals, medical devices, and consumer health.
The takeaway
This filing highlights the ongoing portfolio adjustments and investment decisions of a significant institutional investor, which can provide valuable insights into the market's perception and outlook for Johnson & Johnson's stock.
